Trial Profile
Randomized Placebo-Controlled Trial of Tolvaptan in Hyponatremic Patients With Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2020
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 13 Oct 2015 New trial record